CV Sciences, Inc.
CVSI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $16 | $16 | $16 | $20 |
| % Growth | -1.9% | -1.2% | -19.2% | – |
| Cost of Goods Sold | $9 | $9 | $11 | $11 |
| Gross Profit | $7 | $7 | $6 | $9 |
| % Margin | 45.6% | 44.3% | 34.2% | 43% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $4 | $7 | $4 | $14 |
| SG&A Expenses | $9 | $9 | $12 | $26 |
| Sales & Mktg Exp. | $5 | $3 | $8 | $12 |
| Other Operating Expenses | $0 | -$6 | $0 | $0 |
| Operating Expenses | $9 | $4 | $12 | $27 |
| Operating Income | -$2 | $3 | -$7 | -$18 |
| % Margin | -13.9% | 21% | -42.3% | -92% |
| Other Income/Exp. Net | -$0 | -$0 | -$1 | $3 |
| Pre-Tax Income | -$2 | $3 | -$8 | -$16 |
| Tax Expense | -$0 | -$0 | -$0 | -$0 |
| Net Income | -$2 | $3 | -$8 | -$16 |
| % Margin | -15.2% | 19.4% | -50.7% | -77.6% |
| EPS | -0.014 | 0.02 | -0.06 | -0.14 |
| % Growth | -167.7% | 133.8% | 57.5% | – |
| EPS Diluted | -0.014 | 0.02 | -0.06 | -0.14 |
| Weighted Avg Shares Out | 176 | 154 | 138 | 108 |
| Weighted Avg Shares Out Dil | 176 | 154 | 138 | 108 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $2 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $2 |
| EBITDA | -$2 | $4 | -$6 | -$14 |
| % Margin | -11.8% | 24% | -34.9% | -69.8% |